AARP Responds to 2024 State of the Union Address
WASHINGTON—Today, AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union address: “AARP was encouraged that the State of the Union addressed many of the most important issues to older Americans today, including protecting Social Security, lowering the cost of prescription drugs, and addressing our nation’s caregiving […]
AARP Statement on House Committee Approval on Fiscal Commission Legislation
WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today following the House Budget Committee vote approving fiscal commission proposals that include Social Security and Medicare: “Today’s vote by the House Budget Committee sets up a process where 7 Members of Congress can ram through drastic cuts to […]
AARP Statement on New CMS Proposal to Require Minimum Nursing Home Staffing Levels
AARP Statement on New CMS Proposal to Require Minimum Nursing Home Staffing Levels WASHINGTON— AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services proposal to require federal minimum staffing levels in nursing homes. “COVID-19 revealed what AARP and […]
AARP Responds to First 10 Medicare Part D Drugs Selected for Historic Negotiation
AARP Responds to First 10 Medicare Part D Drugs Selected for Historic Negotiation En español | WASHINGTON— AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ list of the first 10 drugs to be negotiated for lower prices by Medicare: […]
New Report: Top Medicare Part D Drugs Have More Than Tripled in Price Since Entering Market
New Report: Top Medicare Part D Drugs Have More Than Tripled in Price Since Entering Market En español | WASHINGTON — List prices for the 25 brand-name drugs with the highest total Medicare Part D spending in 2021 have increased by an average of 226%—or more than tripled—since they first entered the market, a new report […]
AARP Applauds CMS’ Final Guidance for Medicare Negotiation Implementation to Lower Drug Prices
AARP Applauds CMS’ Final Guidance for Medicare Negotiation Implementation to Lower Drug Prices WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ final implementation guidance of the Medicare Drug Price Negotiation Program: “AARP commends CMS for issuing final […]
AARP Responds to 2023 Social Security and Medicare Trustees’ Reports
En Español | WASHINGTON—AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today: “Today’s Social Security and Medicare Trustees reports reinforce that while they are financially strong today, both programs face long-term funding needs, and Congress must act to find solutions to ensure Social Security and […]
